Health insurer shares pummeled by Sanders surge, virus worries
FILE PHOTO: U.S. presidential candidate Senator Bernie Sanders (I-VT) delivers a speech to defend his support for a sweeping "Medicare for All" healthcare plan at George Washington University in Washington, U.S., July 17, 2019. REUTERS/Erin Scott/File Pho
Get Alerts UNH Hot Sheet
Overall Analyst Rating:
SELL (= Flat)
Dividend Yield: 3.1%
EPS Growth %: +18.9%
Join SI Premium – FREE
By Lewis Krauskopf
NEW YORK (Reuters) - As concerns over the spreading coronavirus outbreak hammered U.S. stocks, one corner of the market was confronted with another potentially game-changing prospect: a Bernie Sanders nomination.
The S&P 500 managed healthcare index of health insurance stocks <.SPLRCHMO> tumbled over 7% early Monday afternoon, compared to a 3.5% fall for the overall S&P 500 <.SPX>. Shares of industry bellwether UnitedHealth Group Inc (NYSE: UNH) dropped 7.6% and were the biggest individual drag on the Dow Jones Industrial Average <.DJI>, while shares of Centene Corp (NYSE: CNC) fell more than 10%.
Sanders, a U.S. senator whose progressive agenda includes a national Medicare for All health plan, scored a dominant win in the Nevada caucuses over the weekend, adding momentum in his bid for the Democratic presidential nomination to face off against U.S. President Donald Trump in the November general election.
The Vermont senator authored Medicare for All legislation that would essentially abolish private insurance in favor of a single government-run plan that covers every American. The ambitious proposal would cost more than $30 trillion over 10 years, according to independent analyses.
His dominant performance has taken some market participants by surprise.
"It wasn't clear that it was going to be that big of a win for him," said Sarah James, a healthcare analyst at Piper Sandler, adding that the senator "is still pushing his Medicare for All, anti-health insurer platform."
James said most investors doubt Sanders' health-reform plan will receive enough support to pass in Congress and would be too disruptive to even be feasible to implement.
"But you have two scenarios," James said, "one, an acknowledgement that the chance isn't absolutely zero; or two, an extension of the uncertainty, neither of which is a great setup."
Health insurer stocks have proved volatile throughout the Democratic presidential race, sometimes falling as polls showed improvement for Sanders and fellow progressive candidate Elizabeth Warren.
(GRAPHIC: Health insurer shares lag in 2020 - https://fingfx.thomsonreuters.com/gfx/editorcharts/USA-HEALTHINSURERS-STOCKS/0H001R8D4C17/eikon.png)
On Monday, the stocks also felt pressure from news that the coronavirus was accelerating its spread outside China, with Italy, South Korea and Iran reporting sharp rises in cases on Monday.
"If it were to become a pandemic in the United States, that would be a significant impact to the operations for managed care," said David Heupel, healthcare analyst at Thrivent Investment Management.
"Obviously you would have a massive increase in ER visits ...," Heupel said. "There's a lot of expenditures associated with that, so this would be a pretty significant increase in cost trend. That plays directly to the managed care group."
Among other health insurer shares, Humana Inc (NYSE: HUM) dropped 6.4%, while Anthem Inc (NYSE: ANTM) was off 5.6%.
Shares of hospital operators were also under pressure, with HCA Healthcare (NYSE: HCA) down 5.6% and Tenet Healthcare Corp (NYSE: THC) off 4.6%.
(Reporting by Lewis Krauskopf; editing by Ira Iosebashvili and Richard Chang)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump's CDC nominee to exit UnitedHealth, divest holdings
- Eleven more bodies of migrants wash ashore from capsize last week off Libya
- Russia weighs fuel imports amid Ukrainian strikes, Crimea restricts public life
Create E-mail Alert Related Categories
ReutersRelated Entities
Donald J. Trump, Elizabeth WarrenSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share